When patients are refractory to first-line treatments for myasthenic crisis, cyclophosphamide may have benefits and warrants further study.
Peter McAllister, MD
There are knowns, unknowns, and bogeymen.
Logan Schneider, MD
Sleep has a critical role in brain health and is an essential part of improving neurologic care for all of our patients.
Raman K. Malhotra, MD
Sleep problems are common and treatable in neurodegenerative disorders, and may also be a treatable risk factor and early biomarker.
Tyler M. Pugeda, BA; Charlene E. Gamaldo, MD, FAAN, FAASM; and Rachel Marie E. Salas, MD, MEdHP, FAAN
New treatments hold promise of increasing efficacy with precision medicine.